Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peppermint Oil PK/PD in Children with Functional Abdominal Pain
NCT04497870Phase 1Withdrawn
- Sponsor
- Baylor College of Medicine
- Start
- Jul 2020
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of peppermint oil in functional abdominal pain (FAP) (2 arms), sponsored by Baylor College of Medicine. Primary endpoints: Pharmacokinetics of peppermint oil at 2 weeks, Gut Microbiome composition at 2 weeks and 2 more. Planned start Jul 2020; status: withdrawn.
02
Drugs
peppermint oil
03
Conditions
functional abdominal pain (FAP)
Beyond the preview
Go deeper on NCT04497870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04497870.